Review bladder disorders and management methods you can discuss with your patients.
November is Bladder Health Month, a month dedicated to raising awareness and promoting education about maintaining a healthy bladder, something that is of particular significance to women. This month serves as an opportunity to dispel misconceptions, provide information, and empower women to prioritize their urinary well-being.
Bladder Health Month aims to shed light on common bladder disorders and offer guidance on preventive measures and management strategies that you can discuss with your patients:
You can perhaps use this month as a way to bring up conversations about bladder health, as these topics are often surrounded by stigma and silence, preventing women from discussing their concerns openly. And there is no better supportive environment than your office, where women can share their experiences, seek advice, and access appropriate care.
Reference
Wyman JF, Burgio KL, Newman DK. Practice aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract. 2009;63(8):1177-1191. doi:10.1111/j.1742-1241.2009.02078.x
(This note was written with the help of ChatGPT.)
Adverse maternal outcomes after uterine conservation in placenta accreta spectrum
May 9th 2024A review of 5 studies reveals a significant 1 in 4 incidence of adverse maternal outcomes following uterine conservation in patients with placenta accreta spectrum, underlining the importance of expert multidisciplinary care.
Read More
Barriers in seeking pelvic floor disorder treatment among ethnic minorities
May 8th 2024A recent shed light on how ethnic minority groups perceive pelvic floor disorders, highlighting barriers to treatment seeking and the importance of raising awareness about available treatment options.
Read More
Variations found in testosterone therapy for women with HSDD
May 7th 2024Dive into the intricate landscape of testosterone therapy prescriptions among women with hypoactive sexual desire disorder, revealing diverse patterns in duration, administration routes, and estrogen co-administration.
Read More